AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14627859 — intervention group
Group type: EXPERIMENTAL
Intervention: 17beta-estradiol gel 2.5 g (1.5 mg estradiol)
Number of subjects: 221
Study 14627859 — intervention group
Group type: EXPERIMENTAL
Intervention: 17beta-estradiol gel 1.25 g (0.75 mg estradiol)
Number of subjects: 221
Study 14627859 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 221
Study 14627859 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (17beta-estradiol gel 2.5 g, 17beta-estradiol gel 1.25 g, placebo)
Number of subjects: 221
Study 11566168 — intervention group
Group type: EXPERIMENTAL
Intervention: 10‐mg atorvastatin
Number of subjects: 19
Study 11566168 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 9569657 — intervention group
Group type: EXPERIMENTAL
Intervention: Trait anxiety
Number of subjects: 0
Study 9569657 — intervention group
Group type: EXPERIMENTAL
Intervention: Impulsivity
Number of subjects: 0
Study 8053744 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine-supplemented TPN (0.18 g of glutamine/kg/d)
Number of subjects: 20
Study 8053744 — intervention group
Group type: COMPARATOR
Intervention: Conventional TPN (0.2 g nitrogen/kg/d)
Number of subjects: 20
Study 8053744 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine-supplemented TPN
Number of subjects: 20
Study 2965375 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (CY 222) at a fixed dose of 750 anti-Xa units
Number of subjects: 68
Study 2965375 — intervention group
Group type: COMPARATOR
Intervention: Standard heparin at a dose of 500 IU/kg/24 h
Number of subjects: 68
Study 8345416 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatotropin, 0.3 mg/kg per week, administered subcutaneously three times weekly (n = 63)
Number of subjects: 121
Study 8345416 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily dosing of somatotropin (n = 92)
Number of subjects: 121
Study 8345416 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-times-weekly dosing of somatotropin (n = 92)
Number of subjects: 121
Study 8345416 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatotropin (n = 92)
Number of subjects: 121
Study 8345416 — intervention group
Group type: COMPARATOR
Intervention: Nontreatment control subjects (n = 58)
Number of subjects: 121
Study 76842 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylalanine mustard (P.A.M.)
Number of subjects: 172
Study 76842 — intervention group
Group type: COMPARATOR
Intervention: Combination of cyclophosphamide, 5‐fluorouracil, and prednisone (C.F.P.) with or without radiotherapy
Number of subjects: 172
Study 29881917 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified milk
Number of subjects: 119
Study 29881917 — intervention group
Group type: COMPARATOR
Intervention: Regular full milk (control)
Number of subjects: 119
Study 28511620 — intervention group
Group type: EXPERIMENTAL
Intervention: Typical voice condition
Number of subjects: 93
Study 28511620 — intervention group
Group type: COMPARATOR
Intervention: Dysphonic voice condition
Number of subjects: 93
Study 26666258 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDI-551, a monoclonal antibody that depletes CD19+ B-cells
Number of subjects: 0
Study 26666258 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24438695 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (group B)
Number of subjects: 98
Study 24438695 — intervention group
Group type: COMPARATOR
Intervention: Three-dimensional conformal radiotherapy alone (group A)
Number of subjects: 98
Study 22712881 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month self-management program led by an Exercise Specialist
Number of subjects: 110
Study 22712881 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 110
Study 19589822 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised home based proprioceptive training programme
Number of subjects: 522
Study 19589822 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 522
Study 17628642 — intervention group
Group type: EXPERIMENTAL
Intervention: Potentized homeopathic remedy Arsenicum Album-30
Number of subjects: 25
Study 17628642 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Succussed Alcohol-30)
Number of subjects: 25
Study 14747397 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% albumin
Number of subjects: 72
Study 14747397 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 72
Study 12021573 — intervention group
Group type: COMPARATOR
Intervention: Tezosentan 100 mg
Number of subjects: 6
Study 12021573 — intervention group
Group type: COMPARATOR
Intervention: Tezosentan 200 mg
Number of subjects: 6
Study 12021573 — intervention group
Group type: COMPARATOR
Intervention: Tezosentan 400 mg
Number of subjects: 6
Study 12021573 — intervention group
Group type: COMPARATOR
Intervention: Tezosentan 600 mg
Number of subjects: 6
Study 12021573 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezosentan (all doses)
Number of subjects: 6
Study 9826295 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with schizophrenia
Number of subjects: 0
Study 9826295 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with ADHD
Number of subjects: 0
Study 9826295 — intervention group
Group type: COMPARATOR
Intervention: Age-matched normal children
Number of subjects: 0
Study 8007742 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Thyroxin Henning
Number of subjects: 0
Study 8007742 — intervention group
Group type: EXPERIMENTAL
Intervention: Another tablet preparation
Number of subjects: 0
Study 8007742 — intervention group
Group type: COMPARATOR
Intervention: Oral solution of levothyroxine (reference solution)
Number of subjects: 0
Study 2509007 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitonin treatment (100 U by subcutaneous self-application on alternate days for 6-8 weeks)
Number of subjects: 28
Study 2509007 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclical hormone replacement therapy (over 12 months)
Number of subjects: 28
Study 2509007 — intervention group
Group type: COMPARATOR
Intervention: Control group (analgetic treatment and 500 mg Ca daily)
Number of subjects: 28
Study 1099526 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg of ASA
Number of subjects: 50
Study 1099526 — intervention group
Group type: COMPARATOR
Intervention: 100 mg of lactose (placebo)
Number of subjects: 50
Study 29932001 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate
Number of subjects: 37
Study 29932001 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 37
Study 28517112 — intervention group
Group type: COMPARATOR
Intervention: Usual care arm participants of a randomized clinical trial
Number of subjects: 91
Study 25932260 — intervention group
Group type: COMPARATOR
Intervention: memantine + placebo
Number of subjects: 110
Study 25932260 — intervention group
Group type: EXPERIMENTAL
Intervention: memantine + huperzine A
Number of subjects: 110
Study 25932260 — intervention group
Group type: EXPERIMENTAL
Intervention: memantine + donepezil
Number of subjects: 110
Study 25932260 — intervention group
Group type: EXPERIMENTAL
Intervention: memantine + rivastigmine
Number of subjects: 110
Study 25932260 — intervention group
Group type: EXPERIMENTAL
Intervention: memantine + galantamine
Number of subjects: 110
Study 23553060 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal Saline (NS) lock
Number of subjects: 802
Study 23553060 — intervention group
Group type: COMPARATOR
Intervention: Heparin lock (300 U/3 ml)
Number of subjects: 802
Study 22212315 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled epidural analgesia (PCEA) with pure ropivacaine
Number of subjects: 120
Study 22212315 — intervention group
Group type: COMPARATOR
Intervention: Intermittent bolus epidural of 2 mg/10 mL morphine
Number of subjects: 120
Study 19638112 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia with sevoflurane (GAS)
Number of subjects: 200
Study 19638112 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia with propofol (GAP)
Number of subjects: 200
Study 16449474 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery from bipolar disorder
Number of subjects: 1469
Study 16449474 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive episodes
Number of subjects: 1469
Study 16449474 — intervention group
Group type: EXPERIMENTAL
Intervention: Manic, hypomanic, or mixed episodes
Number of subjects: 1469
Study 16449474 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to depressive episode
Number of subjects: 1469
Study 16449474 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to manic/hypomanic/mixed episode
Number of subjects: 1469
Study 16449474 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual depressive or manic symptoms
Number of subjects: 1469
Study 16449474 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportion of days depressed or anxious
Number of subjects: 1469
Study 16449474 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportion of days of elevated mood
Number of subjects: 1469
Study 15385829 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of micronized 17beta‐estradiol valerate (E2V)
Number of subjects: 15
Study 15385829 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of E2V in combination with 5 mg of medroxyprogesterone acetate (MPA)
Number of subjects: 15
Study 11041770 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of the World Wide Web for patient randomization and data collection
Number of subjects: 31
Study 9410554 — intervention group
Group type: EXPERIMENTAL
Intervention: Lispro insulin analog
Number of subjects: 189
Study 1564646 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine
Number of subjects: 0
Study 1564646 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine with epinephrine
Number of subjects: 0
Study 1564646 — intervention group
Group type: COMPARATOR
Intervention: Plain Lidocaine
Number of subjects: 0
Study 1564646 — intervention group
Group type: COMPARATOR
Intervention: Plain Bupivacaine
Number of subjects: 0
Study 3896085 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen for 24 months
Number of subjects: 170
Study 3896085 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 24 months
Number of subjects: 170
Study 29941030 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 20
Study 29941030 — intervention group
Group type: COMPARATOR
Intervention: Standard wound management
Number of subjects: 20
Study 28531281 — intervention group
Group type: EXPERIMENTAL
Intervention: INT‐HF‐MP (intensified heart failure management programme)
Number of subjects: 787
Study 28531281 — intervention group
Group type: EXPERIMENTAL
Intervention: INT‐HF‐MP
Number of subjects: 787
Study 28531281 — intervention group
Group type: COMPARATOR
Intervention: SM (standard management)
Number of subjects: 787
Study 26005255 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystectomy
Number of subjects: 60
Study 26005255 — intervention group
Group type: EXPERIMENTAL
Intervention: Puncture with endocoagulation
Number of subjects: 60
Study 26862625 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl-bupivacaine
Number of subjects: 0
Study 26862625 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl-bupivacaine-morphine
Number of subjects: 0
Study 21964681 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant (FS)
Number of subjects: 40
Study 21964681 — intervention group
Group type: COMPARATOR
Intervention: Titanium tacks
Number of subjects: 40
Study 18986288 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study 16645357 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (titrated up to 320 mg)
Number of subjects: 1402
Study 16645357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1402
Study 12813377 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral valve plasty (MVP)
Number of subjects: 225
Study 12813377 — intervention group
Group type: COMPARATOR
Intervention: Mitral valve replacement (MVR)
Number of subjects: 225
Study 12813377 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral valve plasty (MVP) and Mitral valve replacement (MVR)
Number of subjects: 225
Study 10930160 — intervention group
Group type: EXPERIMENTAL
Intervention: MOS-HIV questionnaire
Number of subjects: 296
Study 10930160 — intervention group
Group type: COMPARATOR
Intervention: MQOL-HIV questionnaire
Number of subjects: 296
Study 8912074 — intervention group
Group type: EXPERIMENTAL
Intervention: Early definitive treatment with antrectomy or pyloroplasty
Number of subjects: 36
Study 8912074 — intervention group
Group type: COMPARATOR
Intervention: Gastrostomy plus feeding jejunostomy
Number of subjects: 36
Study 1703618 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse-transcriptase (RT)/PCR
Number of subjects: 40
Study 1703618 — intervention group
Group type: COMPARATOR
Intervention: Solid-phase enzyme immunoassay
Number of subjects: 40
Study 7004479 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol eyedrops followed by adrenaline
Number of subjects: 20
Study 31137959 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly real-time adherence feedback via SMS using Wisepill device
Number of subjects: 0
Study 31137959 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging intervention
Number of subjects: 0
Study 31137959 — intervention group
Group type: EXPERIMENTAL
Intervention: Group adherence feedback
Number of subjects: 0
Study 30077599 — intervention group
Group type: EXPERIMENTAL
Intervention: Stair-stepping bouts for 1, 3, and 10 minutes
Number of subjects: 34
Study 30077599 — intervention group
Group type: EXPERIMENTAL
Intervention: Stair-stepping bouts for 10 minutes
Number of subjects: 34
Study 30077599 — intervention group
Group type: EXPERIMENTAL
Intervention: Stair-stepping bouts for 3 minutes
Number of subjects: 34
Study 30077599 — intervention group
Group type: EXPERIMENTAL
Intervention: Stair-stepping bouts
Number of subjects: 34
Study 25546482 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular Rehabilitation (VR)
Number of subjects: 26
Study 25546482 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 26
Study 26241434 — intervention group
Group type: EXPERIMENTAL
Intervention: Burch colposuspension
Number of subjects: 0
Study 26241434 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous fascial sling
Number of subjects: 0
Study 26241434 — intervention group
Group type: EXPERIMENTAL
Intervention: Retropubic midurethral sling
Number of subjects: 0
Study 26241434 — intervention group
Group type: EXPERIMENTAL
Intervention: Transobturator midurethral sling
Number of subjects: 0
Study 26241434 — intervention group
Group type: COMPARATOR
Intervention: Midurethral sling groups (combined)
Number of subjects: 0
Study 26241434 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall surgical intervention
Number of subjects: 0
Study 23188739 — intervention group
Group type: EXPERIMENTAL
Intervention: Related word pairs
Number of subjects: 0
Study 23188739 — intervention group
Group type: COMPARATOR
Intervention: Unrelated word pairs
Number of subjects: 0
Study 23188739 — intervention group
Group type: EXPERIMENTAL
Intervention: Disrupted fluency by presenting pairs in an alternating format (Experiment 2)
Number of subjects: 0
Study 23188739 — intervention group
Group type: EXPERIMENTAL
Intervention: Measured conceptual fluency (Experiment 3)
Number of subjects: 0
Study 22319901 — intervention group
Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya Yoga for two months
Number of subjects: 26
Study 19541792 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral casopitant 50 mg
Number of subjects: 493
Study 19541792 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral casopitant 100 mg
Number of subjects: 493
Study 19541792 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral casopitant 150 mg
Number of subjects: 493
Study 19541792 — intervention group
Group type: COMPARATOR
Intervention: Control (ondansetron/dexamethasone)
Number of subjects: 493
Study 19541792 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral casopitant 150 mg
Number of subjects: 493
Study 16510744 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab (300 mg, intravenous infusion every four weeks for more than two years)
Number of subjects: 942
Study 16510744 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intravenous infusion every four weeks for more than two years)
Number of subjects: 942
Study 12752404 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN) intravenous infusion
Number of subjects: 8
Study 12752404 — intervention group
Group type: COMPARATOR
Intervention: Placebo intravenous infusion
Number of subjects: 8
Study 10956377 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine, glutathione, alpha-lipoic acid
Number of subjects: 0
Study 10956377 — intervention group
Group type: EXPERIMENTAL
Intervention: L-glutamine
Number of subjects: 0
Study 10956377 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine and acetyl-L-carnitine
Number of subjects: 0
Study 8360397 — intervention group
Group type: EXPERIMENTAL
Intervention: Urea as a marker for ELF volume
Number of subjects: 0
Study 3533564 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 7
Study 3533564 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 7
Study 3533564 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 7
Study 3533564 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 29968301 — intervention group
Group type: EXPERIMENTAL
Intervention: salbutamol (6 × 4 mg oral)
Number of subjects: 12
Study 27054610 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine 25-50mg/day
Number of subjects: 287
Study 27054610 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram 10-20mg/day
Number of subjects: 287
Study 25823155 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 100
Study 25823155 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 100
Study 22868970 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed humidified CO₂ (30 °C, 93 % rH)
Number of subjects: 80
Study 22868970 — intervention group
Group type: COMPARATOR
Intervention: Standard warming measures (Control)
Number of subjects: 80
Study 21084036 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO plus oral oxymetholone (50 mg/tablet twice daily)
Number of subjects: 24
Study 21084036 — intervention group
Group type: COMPARATOR
Intervention: rHuEPO plus placebo
Number of subjects: 24
Study 18958840 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin monotherapy
Number of subjects: 148
Study 18958840 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin and pioglitazone combined treatment
Number of subjects: 148
Study 18958840 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with atorvastatin and pioglitazone
Number of subjects: 148
Study 15973180 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic stem cell transplantation
Number of subjects: 255
Study 12088775 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular Magnetic Resonance (CMR)
Number of subjects: 60
Study 12088775 — intervention group
Group type: COMPARATOR
Intervention: 2-Dimensional Echocardiography
Number of subjects: 60
Study 10492293 — intervention group
Group type: EXPERIMENTAL
Intervention: Music during bronchoscopy
Number of subjects: 60
Study 10492293 — intervention group
Group type: COMPARATOR
Intervention: No music (control)
Number of subjects: 60
Study 8971229 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist orthoses (3 styles)
Number of subjects: 42
Study 8971229 — intervention group
Group type: COMPARATOR
Intervention: Unsplinted condition
Number of subjects: 42
Study 1348641 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined epidural and general anaesthesia with spontaneous ventilation
Number of subjects: 80
Study 1348641 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia with muscle relaxation and ventilation
Number of subjects: 80
Study 3968013 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded elastic (E) loads
Number of subjects: 5
Study 3968013 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded resistive (R) loads
Number of subjects: 5
Study 3968013 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded R in the presence of elevated background R
Number of subjects: 5
Study 30870770 — intervention group
Group type: EXPERIMENTAL
Intervention: ¡Aptívate! (n = 22)
Number of subjects: 42
Study 30870770 — intervention group
Group type: COMPARATOR
Intervention: iCouch CBT (active control; n = 9)
Number of subjects: 42
Study 30870770 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU; n = 11)
Number of subjects: 42
Study 29161988 — intervention group
Group type: EXPERIMENTAL
Intervention: FIFA 11 for Health programme (2×45 minutes per week)
Number of subjects: 931
Study 29161988 — intervention group
Group type: COMPARATOR
Intervention: Obligatory daily school-based physical activity (5×45 minutes per week)
Number of subjects: 931
Study 26886651 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading of 1.0 μg/kg for 20 minutes before the termination of surgery)
Number of subjects: 100
Study 26886651 — intervention group
Group type: COMPARATOR
Intervention: Control (comparable volume of normal saline)
Number of subjects: 100
Study 24576512 — intervention group
Group type: EXPERIMENTAL
Intervention: Faith-based therapeutic lifestyle change (TLC) intervention delivered through 11 weekly sessions and 3 monthly motivational interviewing sessions.
Number of subjects: 0
Study 24576512 — intervention group
Group type: COMPARATOR
Intervention: Health education (HE) control delivered through 11 weekly classes on hypertension and other health topics.
Number of subjects: 0
Study 24576512 — intervention group
Group type: EXPERIMENTAL
Intervention: Faith-based TLC intervention
Number of subjects: 0
Study 24576512 — intervention group
Group type: COMPARATOR
Intervention: Health education (HE) control
Number of subjects: 0
Study 23383460 — intervention group
Group type: EXPERIMENTAL
Intervention: Belt Vessel (Daimai) Regulation Acupoint Recipe with electroacupuncture applied to bilateral GB 26 and ST 25, treatment conducted once every other day for 8 weeks
Number of subjects: 35
Study 20429832 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mm x 32G pen needle
Number of subjects: 173
Study 20429832 — intervention group
Group type: COMPARATOR
Intervention: 5 mm x 31G pen needle
Number of subjects: 173
Study 20429832 — intervention group
Group type: COMPARATOR
Intervention: 8 mm x 31G pen needle
Number of subjects: 173